Sodium-dependent and Equilibrative Nucleoside Transport Systems in LI 210 Mouse Leukemia Cells: Effect of Inhibitors of Equilibrative Systems on the Content and Retention of Nucleosides

Cancer Research

Volumn 50, Issue 20, 1990, Pages 6549-6553

  Dagnino, Lina ^a,b   Paterson, Alan R P ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DILAZEP; DIPYRIDAMOLE; FORMYCIN B; NITROBENZYLTHIOINOSINE; VIDARABINE; VIDARABINE TRIPHOSPHATE;

ARTICLE; LEUKEMIA CELL; LEUKEMIA L 1210; NUCLEOSIDE TRANSPORT; PRIORITY JOURNAL;

ANIMAL; BIOLOGICAL TRANSPORT; DILAZEP; DIPYRIDAMOLE; FORMYCINS; LEUKEMIA L1210; MICE; NUCLEOSIDES; SODIUM; SUPPORT, NON-U.S. GOV'T; THIOINOSINE; VIDARABINE; VIDARABINE PHOSPHATE;

EID: 0025039168     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Gati, W. P., and Paterson, A. R. P. Nucleoside transport. In: P. Agre and J. C. Parker (eds.), Red Blood Cell Membranes, pp. 635–661. New York: Marcel Dekker, Inc., 1989.
2. Plagemann, P. G. W., Wohlhueter, R. MM and Woffendin, C. Nucleoside and nucleobase transport in animal cells. Biochim. Biophys. Acta, 947:405–443, 1988.
3. Spector, R., and Huntoon, S. Specificity and sodium dependence of the active nucleoside transport system in choroid plexus. J. Neurochem., 42: 1048–1052, 1984.
4. Jarvis, S. M. Characterization of sodium-dependent nucleoside transport in rabbit intestinal brush border membrane vesicles. Biochim. Biophys. Acta, 979:132–138,1989.
5. Jakobs, E. S., and Paterson, A. R. P. Sodium-dependent, concentrative nucleoside transport in cultured intestinal epithelial cells. Biochem. Biophys. Res. Commun., 140:1028–1035,1986.
6. Darnowski, J. W., Holdridge, C., and Handschumacher, R. E. Concentrative uridine transport by murine splenocytes: kinetics, substrate specificity and sodium dependence. Cancer Res., 47: 2614–2619, 1987.
7. Paterson, A. R. P., Jakobs, E. S., Harley, E. R., Fu, N. W., Robins, M. J., and Cass, C. E. Inhibition of nucleoside transport. In: R. M. Berne, T. W. Rail, and R. Rubio (eds.), Regulatory Function of Adenosine, pp. 203–220. The Hague: Martinus Nijoff, 1983.
8. Paterson, A. R. P., Jakobs, E. S., Ng, C. Y. C., Odegard, R. D., and Adjei, A. A. Nucleoside transport inhibition in vitro and in vivo. In: E. Gerlach and B. F. Becker (eds.), Topics and Perspectives in Adenosine Research, pp. 89–101. Berlin: Springer-Verlag, 1987.
9. Jarvis, S. M. Nitrobenzylthioinosine-sensitive nucleoside transport system: mechanism of inhibition by dipyridamole. Mol. Pharmacol., 30: 659–665, 1986.
10. Gati, W. P., and Paterson, A. R. P. Interaction of [3H]dilazep at nucleoside transporter-associated binding sites on S49 mouse lymphoma cells. Mol. Pharmacol., 36:134–141, 1989.
11. Paterson, A. R. P., Kolassa, N., and Cass, C. E. Transport of nucleosides in animal cells. Pharmacol. Ther., 12: 515–536, 1981.
12. Cass, C. E., Gaudette, L. A., and Paterson, A. R. P. Mediated transport of nucleosides in human erythrocytes. Specific binding of the inhibitor nitrobenzylthioinosine to nucleoside transport sites in the erythrocyte membrane. Biochim. Biophys. Acta, 345:1–10, 1985.
13. Plagemann, P. G. W., and Wohlhueter, R. M. Nucleoside transport in cultured mammalian cells. Multiple forms with different sensitivity to inhibition by nitrobenzylthioinosine or hypoxanthine. Biochim. Biophys. Acta, 775:39–52,1984.
14. Belt, J. A., and Noel, L. D. Nucleoside transport in Walker 256 rat carcinosarcoma and S49 mouse lymphoma cells. Biochem. J., 232:681–688, 1985.
15. Wohlhueter, R. M., Marz, R., and Plagemann, P. G. W. Properties of the thymidine transport system of Chinese hamster ovary cells as probed by nitrobenzylthioinoine. J. Membr. Biol., 42:247–264, 1978.
16. Dahling-Harley, E., Eilam, Y., and Paterson, A. R. P. Binding of nitrobenzylthioinosine to high-affinity binding sites on the nucleoside transport mechanism of HeLa cells. Biochem. J., 200:295–305, 1981.
17. Belt, J. A. Heterogeneity of nucleoside transport in mammalian cells. Mol. Pharmacol., 24:479–484, 1983.
18. Paterson, A. R. P., Yang, S., Lau, E. Y., and Cass, C. E. Low specificity of the nucleoside transport mechanism of RPMI 6410 cells. Mol. Pharmacol., 76:900–908, 1979.
19. Warnick, C. T., Muzik, H., and Paterson, A. R. P. Interference with nucleoside transport in mouse lymphoma cells proliferating in culture. Cancer Res., 32: 2017–2022, 1972.
20. King, M. E., Naporn, A., Young, B., and Howell, S. B. Modulation of cytarabine uptake and toxicity by dipyridamole. Cancer Treat. Rep., 68:361–366, 1984.
21. Kang, G.-J., and Kimball, A. P. Dipyridamole enhancement of toxicity to LI210 cells by deoxyadenosine and deoxycoformycin combinations in vitro. Cancer Res., 44:461–466, 1984.
22. Plagemann, P. G. W., and Wohlhueter, R. Effects of nucleoside transport inhibitors on the salvage and toxicity of adenosine and deoxyadenosine in LI 210 and P388 mouse leukemia cells. Cancer Res., 45:6418–6424, 1985.
23. Dagnino, L., Bennett, L. L., Jr., and Paterson, A. R. P. Concentrative transport of nucleoside in LI210 mouse leukemia cells. Proc. Am. Assoc. Cancer Res., 28:15, 1987.
24. Dagnino, L., and Paterson, A. R. P. Enhancement in LI210 cells of the content and retention of arabinosyladenine anabolites. Pflügers Arch., 407: S34, 1986.
25. Lynch, P. T., Lauzon, G. J., Naik, S. R., Cass, C. E., and Paterson, A. R. P. Inhibition of nucleoside uptake in HeLa cells by nitrobenzylthioinosinate. Biochem. Pharmacol., 27:1303–1304,1978.
26. Drack, J. C., and Novack, J. M. Some simple thin-layer chromatography systems for the separation of purines and purine nucleosides. Anal. Biochem., 52:633–636,1973.
27. Paterson, A. R. P., Harley, E. R., and Cass, C. E. Inward fluxes of adenosine in erythrocytes and cultured cells measured by a quench-flow method. Biochem. J., 224:1001–1008,1984.
28. Cass, C. E., and Au-Yeung, T. H. Enhancement of 9-β-D-arabinofuranosyladenine toxicity to mouse leukemia in vitro by 2′-deoxycoformycin. Cancer Res., 36: 1486–1491, 1976.
29. Harley, E. R., Paterson, A. R. P., and Cass, C. E. Initial rates of transport of adenosine and tubercidin in cultured cells. Cancer Res., 42: 1289–1295, 1984.
30. Khym, J. X. An analytical system for rapid separation of tissue nucleosides at low pressures on conventional anion exchanger. Clin. Chem., 21: 1245–1252, 1975.
31. Lauzon, G. J., Paran, J. H., and Paterson, A. R. P. Formation of 1–0-d-arabinofuranosylcytosine diphosphate choline in cultured human leukemic RPMI 6410 cells. Cancer Res., 38: 1723–1729, 1978.
32. Spector, R. Thymidine accumulation by choroid plexus in vitro. Arch. Biochem. Biophys., 205: 85–93, 1980.
33. Spector, R., and Huntoon, S. Deoxycytidine transport and metabolism in choroid plexus. J. Neurochem., 40: 1474–1480, 1983.
34. Stein, W. D. Transport and Diffusion Across Cell Membranes, pp. 363–474. Orlando: Academic Press, 1986.
35. Spector, R., and Huntoon, S. Specificity and sodium dependence of the active nucleoside transport system in choroid plexus. J. Neurochem., 42: 1048–1052, 1984.
36. Kimmich, G. A., and Randies, J. Energetics of sugar transport by isolated intestinal epithelial cells: effects of cytochalasin B. Am. J. Physiol., 237: C56-C63, 1979.
37. Kimmich, G. A., and Carter-Su, C. Membrane potentials and the energetics of intestinal Na+-dependent transport systems. Am. J. Physiol., 235: C73-C81, 1978.
38. Lauzon, G. J. The cellular metabolism and lethal effects of 1-β-D-arabinofuranosylcytosine in the presence and absence of other cytotoxic compounds. Ph.D. Dissertation, University of Alberta, Edmonton, Alberta, Canada, 1979.
39. Grem, J. J., and Fisher, P. H. Alteration of fluorouracyl metabolism by dipyridamole with a selective increase in fluorodeoxyuridine monophosphate levels in a human colon cancer cell line (HCT 116). Proc. Am. Assoc. Cancer Res., 27: 294, 1986.
40. Dagnino, L. Sodium-driven nucleoside transport in mouse leukemia LI210 cells. Ph.D. Dissertation, University of Alberta, Edmonton, Alberta, Canada, 1988.
41. Kufe, D. W., Mayor, P. P., Munroe, D., Egan, M., and Herrick, D. Relationship between incorporation of 9–0-D-arabinofuranosyladenine in LI210 DNA and cytotoxicity. Cancer Res., 43: 2000–2004, 1983.
42. Furth, J. J., and Cohen, S. S. Inhibition of mammalian DNA polymerase by the 5′-triphosphate of 1–0-D-arabinofuranosylcytosine and the 5′-triphosphate of 9–0-D-arabinofuranosyladenine. Cancer Res., 28: 2061–2067, 1968.
43. York, J. L., and LePage, G. A. A proposed mechanism for the action of 9-β-D-arabinofuranosyladenine as inhibitor of the growth of some ascites cells. Can. J. Biochem., 44: 19–26, 1966.